{"gene":"MED16","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":2004,"finding":"Drosophila MED16 (and MED23) were identified as subunit-specific coactivators within the Mediator complex: RNAi depletion of MED16 specifically impaired lipopolysaccharide-induced and differentiation-inducing factor (DIF)-induced transcription, and MED16's activator-specific function appeared to result from direct interaction with specific upstream activators, while depletion of other subunits caused general transcriptional defects.","method":"RNA interference depletion of individual Mediator subunits in Drosophila S2 cells, endogenous gene expression assays, synthetic promoter reporter assays, microarray analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — clean KD with defined transcriptional phenotype and activator-specificity, single lab","pmids":["15297616"],"is_preprint":false},{"year":1999,"finding":"MED16 (as TRAP/DRIP subunit) was identified as a component of the DRIP/TRAP/SMCC/Mediator coactivator complex that directly mediates ligand-dependent transcriptional activation by nuclear receptors (VDR, TR) on chromatin templates in cell-free transcription assays; the complex was purified and subunit identities determined by mass spectrometry.","method":"Affinity purification, mass spectrometry, in vitro chromatin transcription assay","journal":"Nature; Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro transcription on chromatin, replicated across two independent studies (DRIP and SMCC/TRAP)","pmids":["10235266","10198638"],"is_preprint":false},{"year":2004,"finding":"MED16 was identified as a consensus subunit of the mammalian Mediator complex by multidimensional protein identification technology (MudPIT) across six independent immunoaffinity-purified Mediator preparations, establishing it as a core component of the mammalian Mediator.","method":"Immunoaffinity purification followed by MudPIT mass spectrometry, six independent Mediator preparations","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — replicated across six independent purifications in same study, consistent with prior biochemical identification","pmids":["15175163"],"is_preprint":false},{"year":2013,"finding":"In yeast Saccharomyces cerevisiae, Med16 (a Tail module subunit) is required for holo-Mediator recruitment to HSP gene promoters in response to heat shock; ablation of Med16 (or Med15) individually reduced Mediator occupancy at HSP promoters, while deletion of both abolished it, concomitantly diminishing RNA polymerase II recruitment. Hsf1 recruits Mediator via its dual N- and C-terminal activation domains cooperating with the Tail module.","method":"ChIP of Mediator subunits and RNA Pol II at HSP promoters, truncation analysis of Hsf1 activation domains, genetic deletion of Med15 and Med16","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal ChIP with multiple subunit deletions and domain mapping, strong mechanistic resolution","pmids":["23447536"],"is_preprint":false},{"year":2013,"finding":"In yeast, cells lacking Med16 displace the entire Tail module from the Head and Middle modules of Mediator. Inactivation of MED15/MED16 together is synthetically lethal, indicating that the Tail performs essential functions even when separated from the core complex. Loss of Med15 (but not Med16 alone) causes G1 cell cycle arrest coinciding with downregulation of Ace2 transcription factor target genes.","method":"N-Degron temperature-sensitive mutants, global gene expression analysis, genetic interaction/synthetic lethality, cell cycle analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis with conditional mutants and transcriptome analysis, single lab","pmids":["23991176"],"is_preprint":false},{"year":2014,"finding":"Cryo-EM structural analysis and subunit localization experiments placed Med16 within the Tail module of the Mediator complex; large-scale conformational rearrangements of Mediator depend on changes at module interfaces, and the Tail module position (where Med16 resides) is conserved between yeast and human Mediator.","method":"Single-particle electron microscopy, subunit localization by antibody labeling, partial X-ray structure docking, biochemical module analysis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — EM structural analysis with subunit localization and biochemical validation","pmids":["24882805"],"is_preprint":false},{"year":2015,"finding":"High-throughput affinity-purification mass spectrometry (BioPlex) identified MED16 as an interaction partner within the human Mediator complex network in HEK293T cells, placing it in a community of Mediator subunits consistent with the Tail module.","method":"Affinity purification mass spectrometry (AP-MS) at proteome scale in HEK293T cells","journal":"Cell","confidence":"Medium","confidence_rationale":"Tier 2 — large-scale AP-MS, high-throughput but not targeted validation of MED16 specifically","pmids":["26186194","28514442","33961781"],"is_preprint":false},{"year":2022,"finding":"In human ER-positive breast cancer cells, MED16 knockdown inhibited cell proliferation, promoted G1 phase cell cycle arrest, reduced tamoxifen sensitivity, and increased autophagy and cancer stem cell properties. The mTOR signaling pathway was regulated by MED16 expression levels, and pharmacological inhibition of mTOR-mediated autophagy restored tamoxifen sensitivity lost upon MED16 downregulation.","method":"siRNA knockdown of MED16 in ER+ BC cell lines, cell proliferation assay, flow cytometry (cell cycle), tamoxifen sensitivity assay, autophagy and stemness assays, mTOR pathway inhibitor rescue","journal":"Life (Basel, Switzerland)","confidence":"Medium","confidence_rationale":"Tier 3 — loss-of-function with multiple phenotypic readouts and pathway rescue, single lab","pmids":["36294896"],"is_preprint":false},{"year":2025,"finding":"Bi-allelic loss-of-function variants in human MED16 cause a multiple congenital anomalies-intellectual disability MEDopathy syndrome. Immunofluorescence assays demonstrated that 16 of 17 patient variants caused mislocalization of MED16 protein from nucleus to cytoplasm, establishing nuclear localization as functionally critical. Homozygous med16 mutant zebrafish showed growth delay and increased mortality; Med16 knockout mice were preweaning lethal.","method":"Exome/genome sequencing of 25 individuals from 18 families, immunofluorescence of patient-variant proteins, homozygous zebrafish mutant phenotyping, Med16 knockout mouse lethality","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — direct protein localization experiments across 17 variants with multiple model organism validations, strong preponderance across 18 families","pmids":["40081376"],"is_preprint":false},{"year":2025,"finding":"Biallelic MED16 variants in humans cause neurodevelopmental disease; the Drosophila ortholog med16 is expressed in CNS neurons and glia, and loss of med16 impairs synaptic transmission and reduces eclosion/lifespan. In iPSC-derived neurons from patients, neurite outgrowth was impaired and rescued by exogenous MED16 expression, establishing loss-of-function pathogenicity. Patient variants preferentially altered transcription of genes related to neuronal maturation.","method":"Drosophila med16 knockout (electrophysiology, behavioral assays), patient iPSC-derived neuron differentiation, neurite outgrowth assay with rescue by exogenous MED16, transcriptomic analysis","journal":"Journal of genetics and genomics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal model systems (fly KO, patient iPSC neurons) with rescue experiment validating loss-of-function mechanism","pmids":["40254158"],"is_preprint":false},{"year":2025,"finding":"Human MED16 dissociates from the core Mediator complex to form a subcomplex with transcription factors UBP1 and TFCP2, identified by protein purification and mass spectrometry. The MED16-UBP1 interaction activates silenced genes involved in lung homeostasis, angiogenesis, and cell proliferation, but suppresses HIV-1 transcription by cooperatively binding near the viral transcriptional start site to inhibit preinitiation complex assembly. Transcriptional outcome (activation vs. repression) depends on whether the UBP1-TFCP2 binding motif is proximal to or overlaps the TSS.","method":"Protein purification coupled with mass spectrometry, gene expression analysis, HIV-1 reporter assays, genomic-scale (ChIP/ATAC) analysis of TSS motif positioning","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — AP-MS identification plus functional gene expression and mechanistic HIV reporter assays, preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.08.12.669905"],"is_preprint":true}],"current_model":"MED16 is a Tail module subunit of the evolutionarily conserved Mediator coactivator complex that bridges upstream transcriptional activators (including nuclear receptors and heat shock factor Hsf1) to RNA polymerase II; its nuclear localization is essential for function, biallelic loss-of-function variants cause a MEDopathy with intellectual disability and congenital anomalies, it regulates cell proliferation and autophagy via mTOR signaling in cancer cells, and it can dissociate from core Mediator to form a context-dependent MED16-UBP1-TFCP2 subcomplex that activates or represses transcription depending on promoter architecture."},"narrative":{"teleology":[{"year":1999,"claim":"Establishing that MED16 is a bona fide subunit of the human Mediator complex answered the foundational question of whether metazoan transcription requires a yeast-like Mediator; purified DRIP/TRAP complexes containing MED16 reconstituted ligand-dependent nuclear-receptor-driven transcription on chromatin.","evidence":"Affinity purification, mass spectrometry, and in vitro chromatin transcription assay using VDR/TR-dependent templates","pmids":["10235266","10198638"],"confidence":"High","gaps":["No direct demonstration that MED16 itself contacts nuclear receptors versus other Tail subunits","Contribution of MED16 versus other subunits within the purified complex not resolved"]},{"year":2004,"claim":"Demonstrating that MED16 is an activator-specific rather than general coactivator resolved how individual Mediator subunits contribute differentially to gene-selective transcription; MED16 depletion selectively impaired LPS- and DIF-induced genes while leaving housekeeping transcription intact.","evidence":"RNAi depletion of individual Mediator subunits in Drosophila S2 cells with endogenous gene expression and reporter assays","pmids":["15297616"],"confidence":"Medium","gaps":["Activator-specificity demonstrated only in Drosophila; mammalian generalizability not tested","Direct physical interaction between MED16 and the specific activators not biochemically validated"]},{"year":2004,"claim":"Proteomic validation across six independent Mediator preparations confirmed MED16 as a consensus mammalian Mediator subunit, settling whether its presence was stoichiometric or substoichiometric.","evidence":"Immunoaffinity purification followed by MudPIT mass spectrometry of six independent Mediator preparations","pmids":["15175163"],"confidence":"High","gaps":["Module assignment within mammalian Mediator not resolved by this approach alone"]},{"year":2013,"claim":"Genetic and ChIP experiments in yeast revealed that Med16 anchors the Tail module to the core Mediator and is required for heat-shock-factor-dependent Mediator recruitment to HSP promoters, defining its role as a Tail-module organizer and activator-recruitment platform.","evidence":"ChIP of Mediator subunits and Pol II at HSP promoters, Hsf1 activation-domain truncations, med15Δ/med16Δ single and double deletions, synthetic lethality analysis","pmids":["23447536","23991176"],"confidence":"High","gaps":["Whether Tail-module detachment upon Med16 loss also occurs in mammalian cells was untested","Structural basis for Med16-dependent Tail–core interaction not resolved"]},{"year":2014,"claim":"Cryo-EM and subunit-localization studies placed Med16 within the Tail module structurally, confirming its conserved position between yeast and human Mediator and revealing large-scale conformational changes at module interfaces.","evidence":"Single-particle electron microscopy with antibody labeling, partial X-ray structure docking","pmids":["24882805"],"confidence":"High","gaps":["Resolution insufficient for atomic-level contacts of MED16 with neighboring subunits","Conformational dynamics of MED16-containing module during transcription initiation not captured"]},{"year":2022,"claim":"Linking MED16 to mTOR-dependent autophagy and tamoxifen resistance in breast cancer cells expanded its functional scope beyond classical transcription coactivation to signaling-coupled cell-fate decisions.","evidence":"siRNA knockdown in ER+ breast cancer cell lines with proliferation, cell cycle, autophagy, and stemness assays; mTOR inhibitor rescue of tamoxifen sensitivity","pmids":["36294896"],"confidence":"Medium","gaps":["Mechanism connecting MED16 transcriptional activity to mTOR pathway regulation not identified","Findings from a single lab with siRNA; genetic knockout confirmation lacking","Relevance to in vivo tumor biology not established"]},{"year":2025,"claim":"Discovery that biallelic MED16 loss-of-function variants cause a human MEDopathy syndrome — with most variants mislocalizing the protein from nucleus to cytoplasm — established nuclear localization as essential and defined MED16 as a disease gene for intellectual disability with congenital anomalies.","evidence":"Exome/genome sequencing of 25 individuals across 18 families, immunofluorescence of 17 patient variants, homozygous zebrafish mutant, Med16 knockout mouse lethality","pmids":["40081376"],"confidence":"High","gaps":["How specific variants alter Mediator complex integrity or activator recruitment is unknown","Tissue-specific transcriptional consequences of hypomorphic alleles not characterized"]},{"year":2025,"claim":"Functional validation in Drosophila and patient iPSC-derived neurons demonstrated that MED16 loss impairs synaptic transmission and neurite outgrowth, with rescue by exogenous MED16 expression confirming loss-of-function pathogenicity and revealing preferential dysregulation of neuronal-maturation genes.","evidence":"Drosophila med16 knockout with electrophysiology and behavior, patient iPSC-derived neuron differentiation with neurite outgrowth assay and rescue, transcriptomic profiling","pmids":["40254158"],"confidence":"High","gaps":["Which downstream transcriptional targets are direct versus indirect is unresolved","Whether MED16 variants disrupt specific activator interactions in neurons is not determined"]},{"year":2025,"claim":"Identification of a free MED16–UBP1–TFCP2 subcomplex that can activate or repress transcription depending on TSS-proximal motif architecture revealed that MED16 has functions independent of the holo-Mediator complex, including suppression of HIV-1 transcription.","evidence":"Protein purification with mass spectrometry, gene expression analysis, HIV-1 reporter assays, ChIP/ATAC-seq motif positioning (preprint)","pmids":["bio_10.1101_2025.08.12.669905"],"confidence":"Medium","gaps":["Preprint not yet peer-reviewed","Stoichiometry and stability of the free subcomplex in vivo not established","Whether MED16 dissociation from Mediator is regulated or constitutive is unknown"]},{"year":null,"claim":"Key unresolved questions include the atomic-resolution structure of MED16 within human Mediator, the identity of MED16's direct activator-binding surfaces, the mechanism by which MED16 loss leads to mTOR pathway dysregulation, and whether the free MED16–UBP1–TFCP2 subcomplex operates in developing neurons to explain the neurodevelopmental phenotype.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of MED16 within the human Mediator Tail module","Direct activator-binding interfaces on MED16 not mapped","Relationship between Mediator-independent MED16 functions and disease phenotype untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,3,10]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[8,9]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,3,10]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[7]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[8,9]}],"complexes":["Mediator complex (Tail module)","MED16-UBP1-TFCP2 subcomplex"],"partners":["MED15","UBP1","TFCP2","HSF1"],"other_free_text":[]},"mechanistic_narrative":"MED16 is a subunit of the Tail module of the Mediator coactivator complex that bridges gene-specific transcriptional activators to the RNA polymerase II general transcription machinery. Biochemically identified as a stoichiometric component of mammalian Mediator (DRIP/TRAP/SMCC), MED16 mediates ligand-dependent activation by nuclear receptors on chromatin templates and is required for activator-specific transcriptional responses, including heat-shock-factor-driven gene expression and lipopolysaccharide-induced transcription [PMID:10235266, PMID:15297616, PMID:23447536]. In yeast, loss of Med16 detaches the entire Tail module from the Head–Middle core, and combined inactivation of Med15 and Med16 is synthetically lethal, demonstrating essential Tail-module functions even when uncoupled from the core complex [PMID:23991176, PMID:24882805]. Biallelic loss-of-function variants in human MED16 cause a multiple congenital anomalies–intellectual disability MEDopathy syndrome, with most patient variants disrupting nuclear localization of the protein; knockout is preweaning lethal in mice and impairs neurite outgrowth in patient iPSC-derived neurons [PMID:40081376, PMID:40254158]."},"prefetch_data":{"uniprot":{"accession":"Q9Y2X0","full_name":"Mediator of RNA polymerase II transcription subunit 16","aliases":["Mediator complex subunit 16","Thyroid hormone receptor-associated protein 5","Thyroid hormone receptor-associated protein complex 95 kDa component","Trap95","Vitamin D3 receptor-interacting protein complex 92 kDa component","DRIP92"],"length_aa":877,"mass_kda":96.8,"function":"Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9Y2X0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MED16","classification":"Not Classified","n_dependent_lines":193,"n_total_lines":1208,"dependency_fraction":0.1597682119205298},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"MED10","stoichiometry":10.0},{"gene":"MED11","stoichiometry":10.0},{"gene":"MED14","stoichiometry":10.0},{"gene":"MED17","stoichiometry":10.0},{"gene":"MED19","stoichiometry":10.0},{"gene":"MED21","stoichiometry":10.0},{"gene":"MED25","stoichiometry":10.0},{"gene":"MED27","stoichiometry":10.0},{"gene":"MED31","stoichiometry":10.0},{"gene":"MED4","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/search/MED16","total_profiled":1310},"omim":[{"mim_id":"621220","title":"GUILLOUET-GORDON SYNDROME; GGNS","url":"https://www.omim.org/entry/621220"},{"mim_id":"615063","title":"SECRETOGLOBIN, FAMILY 2B, MEMBER 2; SCGB2B2","url":"https://www.omim.org/entry/615063"},{"mim_id":"604062","title":"MEDIATOR COMPLEX SUBUNIT 16; MED16","url":"https://www.omim.org/entry/604062"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoli","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MED16"},"hgnc":{"alias_symbol":["DRIP92","TRAP95"],"prev_symbol":["THRAP5"]},"alphafold":{"accession":"Q9Y2X0","domains":[{"cath_id":"-","chopping":"545-723","consensus_level":"high","plddt":88.8503,"start":545,"end":723},{"cath_id":"-","chopping":"740-755_777-834","consensus_level":"medium","plddt":77.2255,"start":740,"end":834}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y2X0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y2X0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y2X0-F1-predicted_aligned_error_v6.png","plddt_mean":84.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MED16","jax_strain_url":"https://www.jax.org/strain/search?query=MED16"},"sequence":{"accession":"Q9Y2X0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y2X0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y2X0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y2X0"}},"corpus_meta":[{"pmid":"24456400","id":"PMC_24456400","title":"The Arabidopsis Mediator subunit MED16 regulates iron homeostasis by associating with EIN3/EIL1 through subunit MED25.","date":"2014","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24456400","citation_count":112,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24415770","id":"PMC_24415770","title":"The Arabidopsis mediator complex subunits MED16, MED14, and MED2 regulate mediator and RNA polymerase II recruitment to CBF-responsive cold-regulated genes.","date":"2014","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/24415770","citation_count":95,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23447536","id":"PMC_23447536","title":"Mediator recruitment to heat shock genes requires dual Hsf1 activation domains and mediator tail subunits Med15 and Med16.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23447536","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15297616","id":"PMC_15297616","title":"MED16 and MED23 of Mediator are coactivators of lipopolysaccharide- and heat-shock-induced transcriptional activators.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15297616","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29203634","id":"PMC_29203634","title":"Mediator Complex Subunits MED2, MED5, MED16, and MED23 Genetically Interact in the Regulation of Phenylpropanoid Biosynthesis.","date":"2017","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/29203634","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28066497","id":"PMC_28066497","title":"The Mediator Complex Subunits MED14, MED15, and MED16 Are Involved in Defense Signaling Crosstalk in Arabidopsis.","date":"2016","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/28066497","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31175173","id":"PMC_31175173","title":"Transcriptional Repression of the APC/C Activator Genes CCS52A1/A2 by the Mediator Complex Subunit MED16 Controls Endoreduplication and Cell Growth in Arabidopsis.","date":"2019","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/31175173","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33369119","id":"PMC_33369119","title":"Mediator tail module subunits MED16 and MED25 differentially regulate abscisic acid signaling in Arabidopsis.","date":"2021","source":"Journal of integrative plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/33369119","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33777083","id":"PMC_33777083","title":"Mediator Subunits MED16, MED14, and MED2 Are Required for Activation of ABRE-Dependent Transcription in Arabidopsis.","date":"2021","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/33777083","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23991176","id":"PMC_23991176","title":"Functional studies of the yeast med5, med15 and med16 mediator tail subunits.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23991176","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39824838","id":"PMC_39824838","title":"A multiprotein regulatory module, MED16-MBR1&2, controls MED25 homeostasis during jasmonate signaling.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39824838","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36294896","id":"PMC_36294896","title":"MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer.","date":"2022","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/36294896","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40081376","id":"PMC_40081376","title":"Bi-allelic MED16 variants cause a MEDopathy with intellectual disability, motor delay, and craniofacial, cardiac, and limb malformations.","date":"2025","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/40081376","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34298953","id":"PMC_34298953","title":"Pantoea Bacteriophage vB_PagS_MED16-A Siphovirus Containing a 2'-Deoxy-7-amido-7-deazaguanosine-Modified DNA.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34298953","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40254158","id":"PMC_40254158","title":"Biallelic MED16 variants disrupt neural development and lead to an intellectual disability syndrome.","date":"2025","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/40254158","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41828689","id":"PMC_41828689","title":"When MED16 Meets Plant Growth, Development, and Stress Response.","date":"2026","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41828689","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.08.12.669905","title":"Mediator Subunit MED16 Collaborates with UBP1-TFCP2 to Control Transcriptional Activation or Repression via Promoter Positional Specificity","date":"2025-08-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.12.669905","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.09.29.25336758","title":"Endophenotype Guided Genome-Wide Association Study to Enhance Genetic Risk Prediction of Primary Open-Angle Glaucoma in African Ancestry Populations","date":"2025-10-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.29.25336758","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10235266","id":"PMC_10235266","title":"Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10235266","citation_count":583,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20211142","id":"PMC_20211142","title":"An atlas of combinatorial transcriptional regulation in mouse and man.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/20211142","citation_count":573,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19410544","id":"PMC_19410544","title":"Centromere-specific assembly of CENP-a nucleosomes is mediated by HJURP.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19410544","citation_count":555,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8710870","id":"PMC_8710870","title":"Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8710870","citation_count":466,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16239144","id":"PMC_16239144","title":"Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16239144","citation_count":443,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10198638","id":"PMC_10198638","title":"Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators.","date":"1999","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/10198638","citation_count":353,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20098423","id":"PMC_20098423","title":"CDK8 is a positive regulator of transcriptional elongation within the serum response network.","date":"2010","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20098423","citation_count":298,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21729782","id":"PMC_21729782","title":"Human mediator subunit MED26 functions as a docking site for transcription elongation factors.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21729782","citation_count":281,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15175163","id":"PMC_15175163","title":"A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15175163","citation_count":265,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25281560","id":"PMC_25281560","title":"Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.","date":"2014","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/25281560","citation_count":215,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14636573","id":"PMC_14636573","title":"Coordination of p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1alpha.","date":"2003","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/14636573","citation_count":210,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29568061","id":"PMC_29568061","title":"An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29568061","citation_count":201,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11337467","id":"PMC_11337467","title":"Identification and characterization of the potential promoter regions of 1031 kinds of human genes.","date":"2001","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11337467","citation_count":188,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23602568","id":"PMC_23602568","title":"The protein interaction landscape of the human CMGC kinase group.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/23602568","citation_count":174,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32807901","id":"PMC_32807901","title":"UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination.","date":"2020","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32807901","citation_count":168,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24882805","id":"PMC_24882805","title":"Subunit architecture and functional modular rearrangements of the transcriptional mediator complex.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/24882805","citation_count":163,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32416067","id":"PMC_32416067","title":"Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/32416067","citation_count":159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30554943","id":"PMC_30554943","title":"Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30554943","citation_count":136,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11867769","id":"PMC_11867769","title":"The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alpha and beta through the TRAP220 subunit and directly enhances estrogen receptor function in vitro.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11867769","citation_count":134,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25720964","id":"PMC_25720964","title":"FBXW7 modulates cellular stress response and metastatic potential through ​HSF1 post-translational modification.","date":"2015","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25720964","citation_count":130,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10014,"output_tokens":1958,"usd":0.029706},"stage2":{"model":"claude-opus-4-6","input_tokens":5210,"output_tokens":1726,"usd":0.1038},"total_usd":0.337851,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":21630,"output_tokens":3634,"usd":0.0597},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6446,"output_tokens":2568,"usd":0.144645}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"Drosophila MED16 functions as a coactivator for lipopolysaccharide-induced transcriptional activators, with its activator-specific function resulting from direct interaction with specific activators; RNAi depletion of MED16 caused defects specifically in LPS- and DIF-induced gene expression without general transcriptional defects.\",\n      \"method\": \"RNAi depletion of individual Mediator subunits combined with transcriptional assays on endogenous and synthetic promoters, microarray analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean RNAi knockdown with specific transcriptional phenotype and activator interaction in Drosophila ortholog; single lab\",\n      \"pmids\": [\"15297616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In yeast, Med16 (Tail module subunit) is required for Mediator recruitment to HSP gene promoters in response to heat shock; Med16 deletion reduces Mediator occupancy, and combined deletion of Med15 and Med16 abolishes Mediator and RNA Pol II recruitment. Mediator antagonizes Hsf1 occupancy at non-induced promoters but facilitates enhanced Hsf1 association at activated promoters.\",\n      \"method\": \"ChIP analysis of Mediator subunit and RNA Pol II occupancy at HSP promoters in deletion mutants; genetic epistasis with Hsf1 activation domain truncations\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal ChIP epistasis with multiple deletion combinations, replicated at multiple loci, in yeast ortholog\",\n      \"pmids\": [\"23447536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In yeast, Med16 is required for physical association of the Tail module with the Head and Middle modules; loss of Med16 displaces Tail from the rest of the Mediator complex. Double inactivation of Med15/Med16 is synthetically lethal, indicating Tail performs essential functions as a separate complex. Med16 inactivation broadly affects gene expression, and Med15 inactivation causes G1 arrest linked to reduced Ace2 target gene expression.\",\n      \"method\": \"N-Degron temperature-sensitive mutants, global gene expression profiling, genetic interaction (synthetic lethality) analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional alleles with genome-wide expression and genetic interaction data in yeast ortholog; single lab\",\n      \"pmids\": [\"23991176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Bi-allelic loss-of-function variants in human MED16 cause a MEDopathy syndrome (intellectual disability, motor delay, craniofacial/cardiac/limb malformations). Missense and in-frame duplication variants destabilize protein structure (3D modeling), and 16/17 variants studied by immunofluorescence showed protein mislocalization from nucleus to cytoplasm. Med16 knockout mice are preweaning lethal; homozygous mutant med16 zebrafish show growth delay and increased mortality.\",\n      \"method\": \"Human genetics (exome sequencing of 25 individuals), 3D structural modeling, immunofluorescence localization assay, zebrafish and mouse knockout models\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (structural modeling, IF mislocalization assay, two animal KO models) across 18 families; strong evidence for nuclear localization requirement\",\n      \"pmids\": [\"40081376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Biallelic MED16 variants in human patients cause intellectual disability with impaired neurite outgrowth in patient-derived iPSC neurons, rescuable by exogenous MED16 expression. The fly ortholog med16 is expressed in neurons and glia; loss of med16 impairs synaptic transmission and reduces eclosion/lifespan. Patient variants behave as loss-of-function alleles in both Drosophila and iPSC systems. Transcription of genes related to neuronal maturation is preferentially altered in patient cells.\",\n      \"method\": \"Human genetics, Drosophila med16 loss-of-function, iPSC differentiation to neurons with neurite outgrowth assay and rescue experiment, RNA-seq of patient cells\",\n      \"journal\": \"Journal of genetics and genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with rescue in iPSC neurons plus Drosophila ortholog validation; multiple orthogonal methods\",\n      \"pmids\": [\"40254158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Human MED16 dissociates from the core Mediator complex to form a subcomplex with transcription factors UBP1 and TFCP2. MED16-UBP1 interaction activates silenced genes involved in lung homeostasis, angiogenesis, and cell proliferation, while cooperatively binding the HIV-1 transcriptional start site to inhibit preinitiation complex assembly and suppress HIV-1 transcription. Transcriptional outcome (activation vs. repression) depends on whether the UBP1-TFCP2 binding motif is proximal to or overlapping the TSS.\",\n      \"method\": \"Protein purification coupled with mass spectrometry (MED16 as UBP1-TFCP2 binding partner), gene expression analyses, genomic-scale ChIP/motif analyses, HIV-1 transcription assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mass spectrometry identification plus functional gene expression and HIV transcription assays; preprint, single lab\",\n      \"pmids\": [\"bio_10.1101_2025.08.12.669905\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MED16 knockdown in ER+ breast cancer cells inhibits cell proliferation, induces G1 phase cell cycle arrest, increases autophagy and stemness, and reduces tamoxifen sensitivity. Inhibition of mTOR-mediated autophagy restores tamoxifen sensitivity lost upon MED16 downregulation, placing MED16 upstream of the mTOR-autophagy axis.\",\n      \"method\": \"siRNA knockdown in ER+ BC cell lines, cell proliferation and cell cycle assays, mTOR pathway inhibitor rescue experiments\",\n      \"journal\": \"Life (Basel, Switzerland)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single KD approach with pharmacological rescue; no direct binding or pathway epistasis at molecular level\",\n      \"pmids\": [\"36294896\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MED16 is a Mediator tail-module subunit that must localize to the nucleus to function; it recruits Mediator and RNA Pol II to target gene promoters by bridging specific transcription factors (including Hsf1 in yeast, UBP1-TFCP2 in humans) to the core transcriptional machinery, and biallelic loss-of-function in humans causes a MEDopathy with intellectual disability and developmental anomalies driven by impaired neuronal gene expression and synaptic function.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries from KEEP papers only.\n\n**Classification:**\n\n- Papers [1]-[9], [11], [16] from retrieved papers: Arabidopsis MED16 — SYMBOL COLLISION (plant gene, fundamentally incompatible domain context with mammalian MED16 MEDopathy protein). EXCLUDE.\n- Paper [3] retrieved: Yeast Med16 in Mediator tail — potential ortholog. KEEP (yeast Mediator tail subunit, consistent with mammalian Mediator architecture).\n- Paper [4] retrieved: Drosophila MED16 — ortholog context. KEEP.\n- Paper [10] retrieved: Yeast med5/med15/med16 functional studies — KEEP (ortholog).\n- Paper [12] retrieved: Human MED16 in breast cancer/mTOR — KEEP.\n- Paper [13] retrieved: Bi-allelic MED16 variants, human MEDopathy — KEEP.\n- Paper [14] retrieved: Bacteriophage vB_PagS_MED16 — EXCLUDE (completely unrelated organism/entity).\n- Paper [15] retrieved: Biallelic MED16 variants, human neurodevelopment — KEEP.\n- Paper [17] PREPRINT: Human MED16-UBP1-TFCP2 — KEEP.\n- Paper [18] PREPRINT: GWAS/eQTL glaucoma — EXCLUDE (no mechanistic findings).\n\n**Gene2pubmed papers:**\n- [1] MGC cDNA — no mechanism. EXCLUDE.\n- [2],[3],[4],[5] BioPlex interactome — MS data showing MED16 in human Mediator complex interactions. KEEP (interactome mapping).\n- [6] Census of human complexes — KEEP (MED16 in complex).\n- [7]-[9],[11]-[13] GO/phylogenetic/promoter annotation — EXCLUDE (no direct mechanism).\n- [8] DRIP complex — KEEP (MED16/TRAP identified as subunit).\n- [10] TF combinatorial atlas — EXCLUDE (no direct MED16 mechanism).\n- [14] OpenCell — KEEP (localization).\n- [15] Metazoan complexes — KEEP.\n- [16] TRAP=SMCC identity — KEEP.\n- [17] CDK8 elongation — not about MED16 specifically. EXCLUDE.\n- [18] MED26 docking — not MED16. EXCLUDE.\n- [19] Consensus mammalian Mediator subunits — KEEP.\n- [20] BioID/AP-MS mediator — KEEP.\n- [21] PGC-1alpha/TRAP/p300 — not MED16 specifically. EXCLUDE.\n- [22] MAC-tag — general, EXCLUDE.\n- [23] Promoter regions — EXCLUDE.\n- [24] CMGC kinase — EXCLUDE.\n- [25]-[30] — not about MED16 specifically. EXCLUDE.\n- [26] Mediator structure (Tsai 2014) — KEEP (subunit localization including tail module).\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"Drosophila MED16 (and MED23) were identified as subunit-specific coactivators within the Mediator complex: RNAi depletion of MED16 specifically impaired lipopolysaccharide-induced and differentiation-inducing factor (DIF)-induced transcription, and MED16's activator-specific function appeared to result from direct interaction with specific upstream activators, while depletion of other subunits caused general transcriptional defects.\",\n      \"method\": \"RNA interference depletion of individual Mediator subunits in Drosophila S2 cells, endogenous gene expression assays, synthetic promoter reporter assays, microarray analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with defined transcriptional phenotype and activator-specificity, single lab\",\n      \"pmids\": [\"15297616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"MED16 (as TRAP/DRIP subunit) was identified as a component of the DRIP/TRAP/SMCC/Mediator coactivator complex that directly mediates ligand-dependent transcriptional activation by nuclear receptors (VDR, TR) on chromatin templates in cell-free transcription assays; the complex was purified and subunit identities determined by mass spectrometry.\",\n      \"method\": \"Affinity purification, mass spectrometry, in vitro chromatin transcription assay\",\n      \"journal\": \"Nature; Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro transcription on chromatin, replicated across two independent studies (DRIP and SMCC/TRAP)\",\n      \"pmids\": [\"10235266\", \"10198638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"MED16 was identified as a consensus subunit of the mammalian Mediator complex by multidimensional protein identification technology (MudPIT) across six independent immunoaffinity-purified Mediator preparations, establishing it as a core component of the mammalian Mediator.\",\n      \"method\": \"Immunoaffinity purification followed by MudPIT mass spectrometry, six independent Mediator preparations\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — replicated across six independent purifications in same study, consistent with prior biochemical identification\",\n      \"pmids\": [\"15175163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In yeast Saccharomyces cerevisiae, Med16 (a Tail module subunit) is required for holo-Mediator recruitment to HSP gene promoters in response to heat shock; ablation of Med16 (or Med15) individually reduced Mediator occupancy at HSP promoters, while deletion of both abolished it, concomitantly diminishing RNA polymerase II recruitment. Hsf1 recruits Mediator via its dual N- and C-terminal activation domains cooperating with the Tail module.\",\n      \"method\": \"ChIP of Mediator subunits and RNA Pol II at HSP promoters, truncation analysis of Hsf1 activation domains, genetic deletion of Med15 and Med16\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal ChIP with multiple subunit deletions and domain mapping, strong mechanistic resolution\",\n      \"pmids\": [\"23447536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In yeast, cells lacking Med16 displace the entire Tail module from the Head and Middle modules of Mediator. Inactivation of MED15/MED16 together is synthetically lethal, indicating that the Tail performs essential functions even when separated from the core complex. Loss of Med15 (but not Med16 alone) causes G1 cell cycle arrest coinciding with downregulation of Ace2 transcription factor target genes.\",\n      \"method\": \"N-Degron temperature-sensitive mutants, global gene expression analysis, genetic interaction/synthetic lethality, cell cycle analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with conditional mutants and transcriptome analysis, single lab\",\n      \"pmids\": [\"23991176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Cryo-EM structural analysis and subunit localization experiments placed Med16 within the Tail module of the Mediator complex; large-scale conformational rearrangements of Mediator depend on changes at module interfaces, and the Tail module position (where Med16 resides) is conserved between yeast and human Mediator.\",\n      \"method\": \"Single-particle electron microscopy, subunit localization by antibody labeling, partial X-ray structure docking, biochemical module analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — EM structural analysis with subunit localization and biochemical validation\",\n      \"pmids\": [\"24882805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"High-throughput affinity-purification mass spectrometry (BioPlex) identified MED16 as an interaction partner within the human Mediator complex network in HEK293T cells, placing it in a community of Mediator subunits consistent with the Tail module.\",\n      \"method\": \"Affinity purification mass spectrometry (AP-MS) at proteome scale in HEK293T cells\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — large-scale AP-MS, high-throughput but not targeted validation of MED16 specifically\",\n      \"pmids\": [\"26186194\", \"28514442\", \"33961781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In human ER-positive breast cancer cells, MED16 knockdown inhibited cell proliferation, promoted G1 phase cell cycle arrest, reduced tamoxifen sensitivity, and increased autophagy and cancer stem cell properties. The mTOR signaling pathway was regulated by MED16 expression levels, and pharmacological inhibition of mTOR-mediated autophagy restored tamoxifen sensitivity lost upon MED16 downregulation.\",\n      \"method\": \"siRNA knockdown of MED16 in ER+ BC cell lines, cell proliferation assay, flow cytometry (cell cycle), tamoxifen sensitivity assay, autophagy and stemness assays, mTOR pathway inhibitor rescue\",\n      \"journal\": \"Life (Basel, Switzerland)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — loss-of-function with multiple phenotypic readouts and pathway rescue, single lab\",\n      \"pmids\": [\"36294896\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Bi-allelic loss-of-function variants in human MED16 cause a multiple congenital anomalies-intellectual disability MEDopathy syndrome. Immunofluorescence assays demonstrated that 16 of 17 patient variants caused mislocalization of MED16 protein from nucleus to cytoplasm, establishing nuclear localization as functionally critical. Homozygous med16 mutant zebrafish showed growth delay and increased mortality; Med16 knockout mice were preweaning lethal.\",\n      \"method\": \"Exome/genome sequencing of 25 individuals from 18 families, immunofluorescence of patient-variant proteins, homozygous zebrafish mutant phenotyping, Med16 knockout mouse lethality\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct protein localization experiments across 17 variants with multiple model organism validations, strong preponderance across 18 families\",\n      \"pmids\": [\"40081376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Biallelic MED16 variants in humans cause neurodevelopmental disease; the Drosophila ortholog med16 is expressed in CNS neurons and glia, and loss of med16 impairs synaptic transmission and reduces eclosion/lifespan. In iPSC-derived neurons from patients, neurite outgrowth was impaired and rescued by exogenous MED16 expression, establishing loss-of-function pathogenicity. Patient variants preferentially altered transcription of genes related to neuronal maturation.\",\n      \"method\": \"Drosophila med16 knockout (electrophysiology, behavioral assays), patient iPSC-derived neuron differentiation, neurite outgrowth assay with rescue by exogenous MED16, transcriptomic analysis\",\n      \"journal\": \"Journal of genetics and genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal model systems (fly KO, patient iPSC neurons) with rescue experiment validating loss-of-function mechanism\",\n      \"pmids\": [\"40254158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Human MED16 dissociates from the core Mediator complex to form a subcomplex with transcription factors UBP1 and TFCP2, identified by protein purification and mass spectrometry. The MED16-UBP1 interaction activates silenced genes involved in lung homeostasis, angiogenesis, and cell proliferation, but suppresses HIV-1 transcription by cooperatively binding near the viral transcriptional start site to inhibit preinitiation complex assembly. Transcriptional outcome (activation vs. repression) depends on whether the UBP1-TFCP2 binding motif is proximal to or overlaps the TSS.\",\n      \"method\": \"Protein purification coupled with mass spectrometry, gene expression analysis, HIV-1 reporter assays, genomic-scale (ChIP/ATAC) analysis of TSS motif positioning\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — AP-MS identification plus functional gene expression and mechanistic HIV reporter assays, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.08.12.669905\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"MED16 is a Tail module subunit of the evolutionarily conserved Mediator coactivator complex that bridges upstream transcriptional activators (including nuclear receptors and heat shock factor Hsf1) to RNA polymerase II; its nuclear localization is essential for function, biallelic loss-of-function variants cause a MEDopathy with intellectual disability and congenital anomalies, it regulates cell proliferation and autophagy via mTOR signaling in cancer cells, and it can dissociate from core Mediator to form a context-dependent MED16-UBP1-TFCP2 subcomplex that activates or represses transcription depending on promoter architecture.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MED16 is a tail-module subunit of the Mediator complex that bridges specific transcription factors to the core transcriptional machinery and RNA Polymerase II at target gene promoters. In yeast, Med16 is required for physical association of the tail module with the head and middle modules and for Mediator recruitment to heat-shock gene promoters in cooperation with Med15 and Hsf1 [PMID:23447536, PMID:23991176]; in Drosophila it functions as a coactivator for innate immune signaling-induced transcription through direct interaction with pathway-specific activators [PMID:15297616]. Nuclear localization is essential for MED16 function, and biallelic loss-of-function variants in humans cause a MEDopathy syndrome characterized by intellectual disability, motor delay, and craniofacial/cardiac/limb malformations, with disease-associated variants driving protein mislocalization to the cytoplasm and impairing neuronal gene expression, neurite outgrowth, and synaptic transmission [PMID:40081376, PMID:40254158].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Establishing that MED16 is not a general transcription factor but an activator-specific coactivator — its depletion selectively impaired innate-immune-induced gene expression in Drosophila without global transcriptional collapse.\",\n      \"evidence\": \"RNAi knockdown of individual Mediator subunits with transcriptional and microarray assays in Drosophila S2 cells\",\n      \"pmids\": [\"15297616\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct physical contacts between Drosophila MED16 and specific activators were not mapped at domain resolution\",\n        \"Whether activator specificity is conserved in mammals was not tested\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrating that Med16 physically connects the tail module to the rest of the Mediator complex and is required for Mediator and Pol II recruitment to activated promoters — answering how a tail subunit can have broad transcriptional effects.\",\n      \"evidence\": \"ChIP of Mediator and Pol II at HSP promoters in yeast deletion mutants; N-degron conditional alleles with genome-wide expression profiling and synthetic lethality analysis\",\n      \"pmids\": [\"23447536\", \"23991176\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for Med16-mediated tail–head/middle module attachment was not resolved\",\n        \"Whether the essential function of the detached tail complex (shown by Med15/Med16 synthetic lethality) involves Mediator-independent gene regulation was not determined\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Linking MED16 to cell proliferation control and tamoxifen sensitivity in breast cancer cells through modulation of the mTOR-autophagy axis — though the direct molecular mechanism remained unclear.\",\n      \"evidence\": \"siRNA knockdown in ER+ breast cancer cell lines with proliferation, cell cycle, and mTOR inhibitor rescue assays\",\n      \"pmids\": [\"36294896\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No direct binding or mechanistic epistasis established between MED16 and mTOR pathway components\",\n        \"Single knockdown approach without rescue by wild-type re-expression\",\n        \"Not replicated in independent labs or in vivo\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Establishing that biallelic MED16 loss-of-function causes a human developmental syndrome (MEDopathy) and that nuclear localization is essential — disease variants mislocalize protein to the cytoplasm, and knockout is lethal in mice and zebrafish.\",\n      \"evidence\": \"Exome sequencing of 25 individuals from 18 families; 3D structural modeling; immunofluorescence of 17 variants; mouse and zebrafish knockout phenotyping\",\n      \"pmids\": [\"40081376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The nuclear localization signal and import mechanism were not defined\",\n        \"How cytoplasmic mislocalization mechanistically disrupts Mediator assembly in patient cells was not shown\",\n        \"Genotype–phenotype correlations across variant classes are not yet resolved\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstrating that MED16 loss specifically impairs neuronal gene expression and synaptic function — patient iPSC neurons show defective neurite outgrowth rescuable by wild-type MED16, and Drosophila med16 mutants have impaired synaptic transmission.\",\n      \"evidence\": \"iPSC differentiation to neurons with neurite outgrowth assay and rescue; Drosophila loss-of-function with electrophysiology; RNA-seq of patient cells\",\n      \"pmids\": [\"40254158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The specific transcription factor partners mediating neuronal gene activation through MED16 in humans are not identified\",\n        \"Whether the synaptic phenotype is cell-autonomous in neurons versus contributed by glia was not resolved\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown which human transcription factors directly recruit MED16-containing Mediator to neuronal gene promoters, what structural determinants govern MED16 nuclear import, and whether MED16 exerts Mediator-independent transcriptional functions as part of a dissociated tail subcomplex in mammalian cells.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural model of human MED16 within the intact Mediator complex at high resolution\",\n        \"Direct transcription-factor-binding surfaces on human MED16 are unmapped\",\n        \"The functional significance of a free MED16-UBP1/TFCP2 subcomplex independent of core Mediator remains unconfirmed in peer-reviewed work\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 2, 4]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 4]}\n    ],\n    \"complexes\": [\n      \"Mediator complex (tail module)\"\n    ],\n    \"partners\": [\n      \"MED15\",\n      \"HSF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"MED16 is a subunit of the Tail module of the Mediator coactivator complex that bridges gene-specific transcriptional activators to the RNA polymerase II general transcription machinery. Biochemically identified as a stoichiometric component of mammalian Mediator (DRIP/TRAP/SMCC), MED16 mediates ligand-dependent activation by nuclear receptors on chromatin templates and is required for activator-specific transcriptional responses, including heat-shock-factor-driven gene expression and lipopolysaccharide-induced transcription [PMID:10235266, PMID:15297616, PMID:23447536]. In yeast, loss of Med16 detaches the entire Tail module from the Head–Middle core, and combined inactivation of Med15 and Med16 is synthetically lethal, demonstrating essential Tail-module functions even when uncoupled from the core complex [PMID:23991176, PMID:24882805]. Biallelic loss-of-function variants in human MED16 cause a multiple congenital anomalies–intellectual disability MEDopathy syndrome, with most patient variants disrupting nuclear localization of the protein; knockout is preweaning lethal in mice and impairs neurite outgrowth in patient iPSC-derived neurons [PMID:40081376, PMID:40254158].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing that MED16 is a bona fide subunit of the human Mediator complex answered the foundational question of whether metazoan transcription requires a yeast-like Mediator; purified DRIP/TRAP complexes containing MED16 reconstituted ligand-dependent nuclear-receptor-driven transcription on chromatin.\",\n      \"evidence\": \"Affinity purification, mass spectrometry, and in vitro chromatin transcription assay using VDR/TR-dependent templates\",\n      \"pmids\": [\"10235266\", \"10198638\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No direct demonstration that MED16 itself contacts nuclear receptors versus other Tail subunits\", \"Contribution of MED16 versus other subunits within the purified complex not resolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrating that MED16 is an activator-specific rather than general coactivator resolved how individual Mediator subunits contribute differentially to gene-selective transcription; MED16 depletion selectively impaired LPS- and DIF-induced genes while leaving housekeeping transcription intact.\",\n      \"evidence\": \"RNAi depletion of individual Mediator subunits in Drosophila S2 cells with endogenous gene expression and reporter assays\",\n      \"pmids\": [\"15297616\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Activator-specificity demonstrated only in Drosophila; mammalian generalizability not tested\", \"Direct physical interaction between MED16 and the specific activators not biochemically validated\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Proteomic validation across six independent Mediator preparations confirmed MED16 as a consensus mammalian Mediator subunit, settling whether its presence was stoichiometric or substoichiometric.\",\n      \"evidence\": \"Immunoaffinity purification followed by MudPIT mass spectrometry of six independent Mediator preparations\",\n      \"pmids\": [\"15175163\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Module assignment within mammalian Mediator not resolved by this approach alone\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Genetic and ChIP experiments in yeast revealed that Med16 anchors the Tail module to the core Mediator and is required for heat-shock-factor-dependent Mediator recruitment to HSP promoters, defining its role as a Tail-module organizer and activator-recruitment platform.\",\n      \"evidence\": \"ChIP of Mediator subunits and Pol II at HSP promoters, Hsf1 activation-domain truncations, med15Δ/med16Δ single and double deletions, synthetic lethality analysis\",\n      \"pmids\": [\"23447536\", \"23991176\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Tail-module detachment upon Med16 loss also occurs in mammalian cells was untested\", \"Structural basis for Med16-dependent Tail–core interaction not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Cryo-EM and subunit-localization studies placed Med16 within the Tail module structurally, confirming its conserved position between yeast and human Mediator and revealing large-scale conformational changes at module interfaces.\",\n      \"evidence\": \"Single-particle electron microscopy with antibody labeling, partial X-ray structure docking\",\n      \"pmids\": [\"24882805\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Resolution insufficient for atomic-level contacts of MED16 with neighboring subunits\", \"Conformational dynamics of MED16-containing module during transcription initiation not captured\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Linking MED16 to mTOR-dependent autophagy and tamoxifen resistance in breast cancer cells expanded its functional scope beyond classical transcription coactivation to signaling-coupled cell-fate decisions.\",\n      \"evidence\": \"siRNA knockdown in ER+ breast cancer cell lines with proliferation, cell cycle, autophagy, and stemness assays; mTOR inhibitor rescue of tamoxifen sensitivity\",\n      \"pmids\": [\"36294896\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism connecting MED16 transcriptional activity to mTOR pathway regulation not identified\", \"Findings from a single lab with siRNA; genetic knockout confirmation lacking\", \"Relevance to in vivo tumor biology not established\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery that biallelic MED16 loss-of-function variants cause a human MEDopathy syndrome — with most variants mislocalizing the protein from nucleus to cytoplasm — established nuclear localization as essential and defined MED16 as a disease gene for intellectual disability with congenital anomalies.\",\n      \"evidence\": \"Exome/genome sequencing of 25 individuals across 18 families, immunofluorescence of 17 patient variants, homozygous zebrafish mutant, Med16 knockout mouse lethality\",\n      \"pmids\": [\"40081376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How specific variants alter Mediator complex integrity or activator recruitment is unknown\", \"Tissue-specific transcriptional consequences of hypomorphic alleles not characterized\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Functional validation in Drosophila and patient iPSC-derived neurons demonstrated that MED16 loss impairs synaptic transmission and neurite outgrowth, with rescue by exogenous MED16 expression confirming loss-of-function pathogenicity and revealing preferential dysregulation of neuronal-maturation genes.\",\n      \"evidence\": \"Drosophila med16 knockout with electrophysiology and behavior, patient iPSC-derived neuron differentiation with neurite outgrowth assay and rescue, transcriptomic profiling\",\n      \"pmids\": [\"40254158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which downstream transcriptional targets are direct versus indirect is unresolved\", \"Whether MED16 variants disrupt specific activator interactions in neurons is not determined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identification of a free MED16–UBP1–TFCP2 subcomplex that can activate or repress transcription depending on TSS-proximal motif architecture revealed that MED16 has functions independent of the holo-Mediator complex, including suppression of HIV-1 transcription.\",\n      \"evidence\": \"Protein purification with mass spectrometry, gene expression analysis, HIV-1 reporter assays, ChIP/ATAC-seq motif positioning (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.08.12.669905\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint not yet peer-reviewed\", \"Stoichiometry and stability of the free subcomplex in vivo not established\", \"Whether MED16 dissociation from Mediator is regulated or constitutive is unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the atomic-resolution structure of MED16 within human Mediator, the identity of MED16's direct activator-binding surfaces, the mechanism by which MED16 loss leads to mTOR pathway dysregulation, and whether the free MED16–UBP1–TFCP2 subcomplex operates in developing neurons to explain the neurodevelopmental phenotype.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of MED16 within the human Mediator Tail module\", \"Direct activator-binding interfaces on MED16 not mapped\", \"Relationship between Mediator-independent MED16 functions and disease phenotype untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 3, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 3, 10]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [8, 9]}\n    ],\n    \"complexes\": [\n      \"Mediator complex (Tail module)\",\n      \"MED16-UBP1-TFCP2 subcomplex\"\n    ],\n    \"partners\": [\n      \"MED15\",\n      \"UBP1\",\n      \"TFCP2\",\n      \"HSF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}